BMS-813160 is the first dual CCR2/CCR5 antagonist to enter clinical development for cardiovascular.
CAS：1286279-29-5
分子式：C25H40N8O2
分子量：484.64
纯度：98%
存储：Store at -20°C

Background:

BMS-813160 is the first dual CCR2/CCR5 antagonist to enter clinical development for cardiovascular.

参考文献:
[1]. Norman P. et al. A dual CCR2/CCR5 chemokine antagonist, BMS-813160 Evaluation of WO2011046916. Expert Opin Ther Pat. 2011 Dec;21(12):1919-24.